Mode of action:
The primary pharmacodynamic effect of Botulinum toxin type A is a chemical denervation of the treated muscle, resulting in a measurable decrease of the compound muscle action potential. This causes a localized reduction of muscle activity. When injected intramuscularly, the toxin induces paralysis of the affected muscle which temporarily reduces muscle activity.
Contraindications:
- Known hypersensitivity to any botulinum toxin products or to any of the excipients.
- Presence of infection at the proposed injection sites.
- Presence of myasthenia gravis, Eaton Lambert Syndrome or amyotrophic lateral sclerosis.
Store in a refrigerator at 2–8°C.
Keep vials in the outer carton in order to protect from light.
Galderma: Relfydess CMI
EMC:Â https://www.medicines.org.uk/emc/product/100710/smpc
Patient Information Leaflet:Â https://www.medicines.org.uk/emc/files/pil.100710.pdf
Verified Customer
Evgenia S. (Verified Customer) –
Anonymous (Verified Customer) –
Product seems good however after removing metal ring and placing bung back in, the vial was accidentally was knocked over and the bung came out waisting all the product with it